Carbamazepine ER
Active substance: carbamazepine
TABLET, EXTENDED RELEASE · CARBAMAZEPINE 200 mg/1
United StatesActive
Marketing holder: Oryza Pharmaceuticals Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
Composition
- CARBAMAZEPINE · 200 mg/1
Registration
- Registration number
- 72516-020
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 72516-020 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 72516-020 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 72516-020 · Verified 2026-10-09 · open in source